Anti fibrin monoclonal antibody 3B6/22 Tc 99m

N/A

Report date: 2025/09/11 11:16:23

Base Information

Drug NameAnti fibrin monoclonal antibody 3B6/22 Tc 99m
Drug Alias NameTc 99m anti-fibrin monoclonal antibody 3B6/2299mTc-Fab′Antifibrin humanized monoclonal antibody Fab 'protein fragment conjugated with technetium 99 mTcAnti-Fibrin Humanized Monoclonal Antibody (DI-DD3B6/22-80B3) Fab' Protein Fragment (ThromboView) Conjugated With Technetium-99mThromboView +[6] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedRadiation-emitting products > Radioactive therapeutic agent +[5] 
Mechanisms of ActionFibrin modulators
TargetsFibrinogen
Therapy Area/IndicationsVenous Thrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAgenix
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAgen Biomedical Ltd
Active IndicationsN/A
Inactive IndicationsVenous Thrombosis

Other Information

ATC CodeN/A
Related LinksN/A